Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes
An Open-label, Randomized, Three-way, Multicenter Study to Compare the Efficacy of Single-hormone Closed-loop Strategy, Dual-hormone Closed-loop Strategy and Conventional Insulin Pump Therapy in Regulating Overnight Glucose Levels at Home in Adolescents and Adults With Type 1 Diabetes
Sponsor: Institut de Recherches Cliniques de Montreal
Listed as NCT01905020, this PHASE2 trial focuses on Type 1 Diabetes and remains completed. Sponsored by Institut de Recherches Cliniques de Montreal, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut de Recherches Cliniques de Montreal
- McGill University
- Montreal Children's Hospital of the MUHC
- Mount Sinai Hospital, New York
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Montreal, Canada
- • Toronto, Canada